Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation

Table 1 Demographic and clinical characteristics of patients undergoing radiofrequency ablation, n (%)/mean ± SD

Variable	Groups	All patients
Age (years)		60.879 ± 9.03
Gender	Male	68 (74.73)
	Female	23 (25.27)
Number of lesions	≤ 2	83 (91.21)
	> 2	8 (8.79)
Maximum diameter of lesions (mm)	Hepatitis A	26.27 ± 13.80
Hepatitis virus history	Hepatitis B	71 (78.02)
	Hepatitis C	8 (8.79)
	No	12 (13.19)
Artificial ascites	Yes	25 (27.47)
	No	66 (72.53)
Ascites	Yes	9 (9.89)
	No	82 (90.11)
Child-Pugh grade	A	90 (98.90)
	B	1 (1.10)

Table 2 Univariate logistic regression analysis of post-radiofrequency ablation inflammatory markers and clinical parameters

Factor	Odds ratio	95%CI	P value
IL-6/IL-10 ratio	1.09	1.02-1.17	0.01
Albumin (G/L)	0.86	0.74-0.99	0.046
Aspartate aminotransferase (IU/L)	1.00	1.00-1.01	0.017

IL: Interleukin.

Table 3 Multivariate logistic regression analysis of post-radiofrequency ablation inflammatory markers and clinical parameters

Factor	β value	Odds ratio	95%CI	P value
Intercept value	3.35	28.49	0.08-3.66	0.268
IL-6/IL-10 ratio	0.11	1.11	1.033-1.204	0.006
Albumin (G/L)	-0.21	0.81	0.668-0.961	0.020
Aspartate aminotransferase (IU/L)	0.004	1.004	1.002-1.007	0.002

IL: Interleukin.